-+ 0.00%
-+ 0.00%
-+ 0.00%

INMED PHARMACEUTICALS: POST DEAL, COMBINED COMPANY TO HAVE PRO FORMA EQUITY VALUE OF ABOUT US$421.4 MLN (INCLUSIVE OF PRIVATE PLACEMENT)

Reuters·05/19/2026 12:00:09

Please log in to view news